Global Bioresorbable Implants Market - 2025-2033
Overview
The global bioresorbable implants market reached US$ 7.00 billion in 2024 and is expected to reach US$ 14.34 billion by 2033, growing at a CAGR of 7.4% during the forecast period 2025-2033.
Bioresorbable implants are medical devices made from specially engineered polymers that naturally dissolve or degrade within the body over time, eliminating the need for surgical removal once their function is complete. These implants are composed of either hydrophobic or hydrophilic polymers and are designed to support healing processes in various medical applications, particularly after surgery.
They are available in a wide range of forms and are commonly used in orthopedic procedures, tissue repair, and drug delivery systems. As they gradually break down into non-toxic byproducts that are safely absorbed or excreted by the body, bioresorbable implants offer a less invasive, patient-friendly alternative to permanent implants, reducing the risk of long-term complications and the need for additional surgeries.
Market Dynamics: Drivers & Restraints
Rising Development of Advanced Implants with Innovative Materials
The rising development of implants utilizing innovative materials is significantly driving the growth of the bioresorbable implants market. Advancements in material science have led to the creation of bioresorbable polymers and composites that offer improved mechanical strength, biocompatibility, and controlled degradation rates. For instance, the integration of bioactive glass and magnesium-based alloys into implant designs has enhanced their functionality and healing capabilities.
These innovations enable the development of implants that not only support healing but also promote tissue regeneration, thereby expanding their applications across various medical specialties. In January 2025, Bioretec, a pioneer in absorbable orthopedic implants, has completed its CE mark approval process and can start commercialization of its RemeOs Trauma Screw product portfolio within the European Union and non-European countries that recognize the CE mark market authorization. This comprehensive approval covers all cannulated and non-cannulated product designs, with sizes ranging from diameters of 2.0mm to 4.0mm and lengths from 8mm to 50mm. Indications approved include the use of these screws for fracture and malalignment fixations in both upper and lower extremities of adult and pediatric patients, excluding the hand and forefoot.
Additionally, the incorporation of smart technologies, such as sensors and drug delivery systems, into bioresorbable implants allows for real-time monitoring and targeted treatment, further enhancing patient outcomes. These technological advancements are making bioresorbable implants more effective and versatile, thereby accelerating their adoption in clinical settings.
High Cost of Designing and Manufacturing
The high cost of designing and manufacturing bioresorbable implants remains a major barrier to the market's broader adoption. These implants require advanced materials, specialized production techniques, and extensive research and testing to ensure biocompatibility and precise degradation rates. Processes like 3D printing, polymer blending, and surface modification demand sophisticated equipment and skilled labor, all of which significantly drive up production costs.
Segment Analysis
The global bioresorbable implants market is segmented based on material type, application, and end-user region.
Material Type:
PLGA (Poly lactic-co-glycolic acid) in the material type segment is expected to dominate the bioresorbable implants market.
PLGA (Poly lactic-co-glycolic acid) is expected to dominate the bioresorbable implants market due to its exceptional versatility, safety profile, and broad range of clinical applications. As a copolymer of lactic acid and glycolic acid, PLGA offers customizable degradation rates by simply altering the ratio of its two components, allowing it to be tailored for everything from short-term tissue scaffolds to longer-term orthopedic or cardiovascular support. Its biocompatibility and non-toxic degradation byproducts (carbon dioxide and water) make it ideal for implantation, with minimal risk of inflammation or rejection.
PLGA is already widely used in FDA-approved medical devices, including sutures, screws, pins, and drug-delivery systems, which has established a strong regulatory precedent for new product approvals. Moreover, PLGA’s role in controlled drug release has expanded its utility beyond just structural support. Given its proven track record, ease of processing, and adaptability across various specialties like orthopedics, cardiology, and regenerative medicine, the PLGA segment is well-positioned to remain a leading force in the global bioresorbable implants market.
Geographical Analysis
North America is expected to dominate the global bioresorbable implants market.
North America is expected to dominate the bioresorbable implants market due to rising surgical volumes, growing adoption of advanced medical technologies, and increasing demand for patient-friendly treatment options. The region, particularly the United States, has seen a steady rise in procedures such as orthopedic repairs, soft tissue reconstruction, and cardiovascular interventions.
For instance, according to the American College of Rheumatology, in 2024, about 790,000 total knee replacements and 544,000 hip replacements were done every year in the U.S. This number continues to grow as our population ages. This increase in the number of procedures is expected to increase the demand for bioresorbable implants, as a large number of individuals in the region are hesitating about the removal surgery of implants.
Additionally, a strong focus on reducing long-term complications and avoiding secondary surgeries has led to higher acceptance of bioresorbable devices like screws, pins, and plates. Recent product approvals, such as magnesium-based bioresorbable implants, and growing use of materials like PLGA and PLLA further support this trend.
With a well-established regulatory pathway and a high level of awareness among healthcare providers, North America is expected to maintain its leading position in the global bioresorbable implants market. For instance, In March 2023, Bioretec Ltd received the market authorization of the U.S. Food and Drug Administration (FDA) for its pioneering RemeOs trauma screw to be used for healing of bone fractures aligned with the clinical trial.
Competitive Landscape
The global market players in the bioresorbable implants market include Bioretec Ltd, Stryker Corporation, CONMED Corporation, Syntellix AG, Johnson & Johnson Medical Devices (DePuy Synthes), Zimmer Biomet, NuVasive Inc., KLS Martin Group, Smith+Nephew, Evonik Industries AG, among others.
Why Purchase the Report?
Target Audience 2024
The global bioresorbable implants market reached US$ 7.00 billion in 2024 and is expected to reach US$ 14.34 billion by 2033, growing at a CAGR of 7.4% during the forecast period 2025-2033.
Bioresorbable implants are medical devices made from specially engineered polymers that naturally dissolve or degrade within the body over time, eliminating the need for surgical removal once their function is complete. These implants are composed of either hydrophobic or hydrophilic polymers and are designed to support healing processes in various medical applications, particularly after surgery.
They are available in a wide range of forms and are commonly used in orthopedic procedures, tissue repair, and drug delivery systems. As they gradually break down into non-toxic byproducts that are safely absorbed or excreted by the body, bioresorbable implants offer a less invasive, patient-friendly alternative to permanent implants, reducing the risk of long-term complications and the need for additional surgeries.
Market Dynamics: Drivers & Restraints
Rising Development of Advanced Implants with Innovative Materials
The rising development of implants utilizing innovative materials is significantly driving the growth of the bioresorbable implants market. Advancements in material science have led to the creation of bioresorbable polymers and composites that offer improved mechanical strength, biocompatibility, and controlled degradation rates. For instance, the integration of bioactive glass and magnesium-based alloys into implant designs has enhanced their functionality and healing capabilities.
These innovations enable the development of implants that not only support healing but also promote tissue regeneration, thereby expanding their applications across various medical specialties. In January 2025, Bioretec, a pioneer in absorbable orthopedic implants, has completed its CE mark approval process and can start commercialization of its RemeOs Trauma Screw product portfolio within the European Union and non-European countries that recognize the CE mark market authorization. This comprehensive approval covers all cannulated and non-cannulated product designs, with sizes ranging from diameters of 2.0mm to 4.0mm and lengths from 8mm to 50mm. Indications approved include the use of these screws for fracture and malalignment fixations in both upper and lower extremities of adult and pediatric patients, excluding the hand and forefoot.
Additionally, the incorporation of smart technologies, such as sensors and drug delivery systems, into bioresorbable implants allows for real-time monitoring and targeted treatment, further enhancing patient outcomes. These technological advancements are making bioresorbable implants more effective and versatile, thereby accelerating their adoption in clinical settings.
High Cost of Designing and Manufacturing
The high cost of designing and manufacturing bioresorbable implants remains a major barrier to the market's broader adoption. These implants require advanced materials, specialized production techniques, and extensive research and testing to ensure biocompatibility and precise degradation rates. Processes like 3D printing, polymer blending, and surface modification demand sophisticated equipment and skilled labor, all of which significantly drive up production costs.
Segment Analysis
The global bioresorbable implants market is segmented based on material type, application, and end-user region.
Material Type:
PLGA (Poly lactic-co-glycolic acid) in the material type segment is expected to dominate the bioresorbable implants market.
PLGA (Poly lactic-co-glycolic acid) is expected to dominate the bioresorbable implants market due to its exceptional versatility, safety profile, and broad range of clinical applications. As a copolymer of lactic acid and glycolic acid, PLGA offers customizable degradation rates by simply altering the ratio of its two components, allowing it to be tailored for everything from short-term tissue scaffolds to longer-term orthopedic or cardiovascular support. Its biocompatibility and non-toxic degradation byproducts (carbon dioxide and water) make it ideal for implantation, with minimal risk of inflammation or rejection.
PLGA is already widely used in FDA-approved medical devices, including sutures, screws, pins, and drug-delivery systems, which has established a strong regulatory precedent for new product approvals. Moreover, PLGA’s role in controlled drug release has expanded its utility beyond just structural support. Given its proven track record, ease of processing, and adaptability across various specialties like orthopedics, cardiology, and regenerative medicine, the PLGA segment is well-positioned to remain a leading force in the global bioresorbable implants market.
Geographical Analysis
North America is expected to dominate the global bioresorbable implants market.
North America is expected to dominate the bioresorbable implants market due to rising surgical volumes, growing adoption of advanced medical technologies, and increasing demand for patient-friendly treatment options. The region, particularly the United States, has seen a steady rise in procedures such as orthopedic repairs, soft tissue reconstruction, and cardiovascular interventions.
For instance, according to the American College of Rheumatology, in 2024, about 790,000 total knee replacements and 544,000 hip replacements were done every year in the U.S. This number continues to grow as our population ages. This increase in the number of procedures is expected to increase the demand for bioresorbable implants, as a large number of individuals in the region are hesitating about the removal surgery of implants.
Additionally, a strong focus on reducing long-term complications and avoiding secondary surgeries has led to higher acceptance of bioresorbable devices like screws, pins, and plates. Recent product approvals, such as magnesium-based bioresorbable implants, and growing use of materials like PLGA and PLLA further support this trend.
With a well-established regulatory pathway and a high level of awareness among healthcare providers, North America is expected to maintain its leading position in the global bioresorbable implants market. For instance, In March 2023, Bioretec Ltd received the market authorization of the U.S. Food and Drug Administration (FDA) for its pioneering RemeOs trauma screw to be used for healing of bone fractures aligned with the clinical trial.
Competitive Landscape
The global market players in the bioresorbable implants market include Bioretec Ltd, Stryker Corporation, CONMED Corporation, Syntellix AG, Johnson & Johnson Medical Devices (DePuy Synthes), Zimmer Biomet, NuVasive Inc., KLS Martin Group, Smith+Nephew, Evonik Industries AG, among others.
Why Purchase the Report?
- Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming pharmaceutical advancements.
- Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
- Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
- Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
- Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
- Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
- Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
- Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
- Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
- Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
- Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
- Post-market Surveillance: Uses post-market data to enhance product safety and access.
- Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
Target Audience 2024
- Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
- Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
- Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
- Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
- Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
- Supply Chain: Distribution and Supply Chain Managers.
- Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
- Academic & Research: Academic Institutions.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Material Type
2.4. Snippet by Application
2.5. Snippet by End-User
2.6. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Number of Approvals
3.1.1.2. Rising Development of Implants with Innovative Materials
3.1.1.3. XX
3.1.2. Restraints
3.1.2.1. High Cost of Designing and Manufacturing
3.1.2.2. Limited Awareness Among Healthcare Professionals
3.1.2.3. XX
3.1.3. Opportunity
3.1.3.1. Shift Toward Minimally Invasive and Patient-centric Healthcare Solutions
3.1.3.2. XX
3.1.4. Impact Analysis
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest selling Brand
4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Case Studies/Ongoing Research
4.5. Regulatory and Reimbursement Landscape
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. South America
4.5.5. Middle East & Africa
4.6. Porter’s Five Force Analysis
4.7. Supply Chain Analysis
4.8. Patent Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics
4.14. Key Opinion Leaders
5. BIORESORBABLE IMPLANTS MARKET, BY MATERIAL TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
5.1.2. Market Attractiveness Index, By Material Type
5.2. Metallic*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Polymers
5.4. PLGA- Poly lactic-co-glycolic acid
5.5. PLLA- Poly L-lactide
5.6. PGA- Polyglycolic Acid
5.7. PLA- Polylactic Acid
5.8. Others
6. BIORESORBABLE IMPLANTS MARKET, BY APPLICATION
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
6.1.2. Market Attractiveness Index, By Application
6.2. Cardiovascular*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Orthopedics
6.4. Others
7. BIORESORBABLE IMPLANTS MARKET, BY END-USER
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.1.2. Market Attractiveness Index, By End-User
7.2. Hospitals*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ambulatory Surgical Centers
7.4. Others
8. BIORESORBABLE IMPLANTS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.6.1. U.S.
8.2.6.2. Canada
8.2.6.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.6.1. Germany
8.3.6.2. U.K.
8.3.6.3. France
8.3.6.4. Spain
8.3.6.5. Italy
8.3.6.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.6.1. Brazil
8.4.6.2. Argentina
8.4.6.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.6.1. China
8.5.6.2. India
8.5.6.3. Japan
8.5.6.4. South Korea
8.5.6.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. COMPANY PROFILES
10.1. Bioretec Ltd*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.2.3. Historic and Forecasted Product Sales
10.1.2.4. Product Sales Volume
10.1.3. Financial Overview
10.1.3.1. Company Revenue
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals, etc.
10.1.5. SWOT Analysis
10.2. Stryker Corporation
10.3. CONMED Corporation
10.4. Syntellix AG
10.5. Johnson & Johnson Medical Devices (DePuy Synthes)
10.6. Zimmer Biomet
10.7. NuVasive Inc.
10.8. KLS Martin Group
10.9. Smith+Nephew
10.10. Evonik Industries AG
* indicates “similar data will be provided for each market player.”
LIST NOT EXHAUSTIVE
11. ASSUMPTION AND RESEARCH METHODOLOGY
11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation
12. APPENDIX
12.1. About Us and Services
12.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Material Type
2.4. Snippet by Application
2.5. Snippet by End-User
2.6. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Number of Approvals
3.1.1.2. Rising Development of Implants with Innovative Materials
3.1.1.3. XX
3.1.2. Restraints
3.1.2.1. High Cost of Designing and Manufacturing
3.1.2.2. Limited Awareness Among Healthcare Professionals
3.1.2.3. XX
3.1.3. Opportunity
3.1.3.1. Shift Toward Minimally Invasive and Patient-centric Healthcare Solutions
3.1.3.2. XX
3.1.4. Impact Analysis
4. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest selling Brand
4.1.3. Market leaders with established Product
4.2. CXO Perspectives
4.3. Latest Developments and Breakthroughs
4.4. Case Studies/Ongoing Research
4.5. Regulatory and Reimbursement Landscape
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. South America
4.5.5. Middle East & Africa
4.6. Porter’s Five Force Analysis
4.7. Supply Chain Analysis
4.8. Patent Analysis
4.9. SWOT Analysis
4.10. Unmet Needs and Gaps
4.11. Recommended Strategies for Market Entry and Expansion
4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
4.13. Pricing Analysis and Price Dynamics
4.14. Key Opinion Leaders
5. BIORESORBABLE IMPLANTS MARKET, BY MATERIAL TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
5.1.2. Market Attractiveness Index, By Material Type
5.2. Metallic*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Polymers
5.4. PLGA- Poly lactic-co-glycolic acid
5.5. PLLA- Poly L-lactide
5.6. PGA- Polyglycolic Acid
5.7. PLA- Polylactic Acid
5.8. Others
6. BIORESORBABLE IMPLANTS MARKET, BY APPLICATION
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
6.1.2. Market Attractiveness Index, By Application
6.2. Cardiovascular*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Orthopedics
6.4. Others
7. BIORESORBABLE IMPLANTS MARKET, BY END-USER
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.1.2. Market Attractiveness Index, By End-User
7.2. Hospitals*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ambulatory Surgical Centers
7.4. Others
8. BIORESORBABLE IMPLANTS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.6.1. U.S.
8.2.6.2. Canada
8.2.6.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.6.1. Germany
8.3.6.2. U.K.
8.3.6.3. France
8.3.6.4. Spain
8.3.6.5. Italy
8.3.6.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.6.1. Brazil
8.4.6.2. Argentina
8.4.6.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.6.1. China
8.5.6.2. India
8.5.6.3. Japan
8.5.6.4. South Korea
8.5.6.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. COMPANY PROFILES
10.1. Bioretec Ltd*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.2.3. Historic and Forecasted Product Sales
10.1.2.4. Product Sales Volume
10.1.3. Financial Overview
10.1.3.1. Company Revenue
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals, etc.
10.1.5. SWOT Analysis
10.2. Stryker Corporation
10.3. CONMED Corporation
10.4. Syntellix AG
10.5. Johnson & Johnson Medical Devices (DePuy Synthes)
10.6. Zimmer Biomet
10.7. NuVasive Inc.
10.8. KLS Martin Group
10.9. Smith+Nephew
10.10. Evonik Industries AG
* indicates “similar data will be provided for each market player.”
LIST NOT EXHAUSTIVE
11. ASSUMPTION AND RESEARCH METHODOLOGY
11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation
12. APPENDIX
12.1. About Us and Services
12.2. Contact Us
LIST OF TABLES
Table 1 Global Bioresorbable Implants Market Value, By Material Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Bioresorbable Implants Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Bioresorbable Implants Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Bioresorbable Implants Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Bioresorbable Implants Market Value, By Material Type, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Bioresorbable Implants Market Value, By Material Type, 2022-2033 (US$ Billion)
Table 7 Global Bioresorbable Implants Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Bioresorbable Implants Market Value, By Application, 2022-2033 (US$ Billion)
Table 9 Global Bioresorbable Implants Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Bioresorbable Implants Market Value, By End-User, 2022-2033 (US$ Billion)
Table 11 Global Bioresorbable Implants Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Bioresorbable Implants Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America Bioresorbable Implants Market Value, By Material Type, 2022-2033 (US$ Billion)
Table 14 North America Bioresorbable Implants Market Value, By Application, 2022-2033 (US$ Billion)
Table 15 North America Bioresorbable Implants Market Value, By End-User, 2022-2033 (US$ Billion)
Table 16 North America Bioresorbable Implants Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 South America Bioresorbable Implants Market Value, By Material Type, 2022-2033 (US$ Billion)
Table 18 South America Bioresorbable Implants Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 South America Bioresorbable Implants Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 South America Bioresorbable Implants Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Bioresorbable Implants Market Value, By Material Type, 2022-2033 (US$ Billion)
Table 22 Europe Bioresorbable Implants Market Value, By Application, 2022-2033 (US$ Billion)
Table 23 Europe Bioresorbable Implants Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 Europe Bioresorbable Implants Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Bioresorbable Implants Market Value, By Material Type, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Bioresorbable Implants Market Value, By Application, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Bioresorbable Implants Market Value, By End-User, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Bioresorbable Implants Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa Bioresorbable Implants Market Value, By Material Type, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa Bioresorbable Implants Market Value, By Application, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa Bioresorbable Implants Market Value, By End-User, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa Bioresorbable Implants Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 Bioretec Ltd: Overview
Table 34 Bioretec Ltd: Product Portfolio
Table 35 Bioretec Ltd: Key Developments
Table 36 Stryker Corporation: Overview
Table 37 Stryker Corporation: Product Portfolio
Table 38 Stryker Corporation: Key Developments
Table 39 CONMED Corporation: Overview
Table 40 CONMED Corporation: Product Portfolio
Table 41 CONMED Corporation: Key Developments
Table 42 Syntellix AG: Overview
Table 43 Syntellix AG: Product Portfolio
Table 44 Syntellix AG: Key Developments
Table 45 Johnson & Johnson Medical Devices (DePuy Synthes): Overview
Table 46 Johnson & Johnson Medical Devices (DePuy Synthes): Product Portfolio
Table 47 Johnson & Johnson Medical Devices (DePuy Synthes): Key Developments
Table 48 Zimmer Biomet: Overview
Table 49 Zimmer Biomet: Product Portfolio
Table 50 Zimmer Biomet: Key Developments
Table 51 NuVasive Inc.: Overview
Table 52 NuVasive Inc.: Product Portfolio
Table 53 NuVasive Inc.: Key Developments
Table 54 KLS Martin Group: Overview
Table 55 KLS Martin Group: Product Portfolio
Table 56 KLS Martin Group: Key Developments
Table 57 Smith+Nephew: Overview
Table 58 Smith+Nephew: Product Portfolio
Table 59 Smith+Nephew: Key Developments
Table 60 Evonik Industries AG: Overview
Table 61 Evonik Industries AG: Product Portfolio
Table 62 Evonik Industries AG: Key Developments
Table 1 Global Bioresorbable Implants Market Value, By Material Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Bioresorbable Implants Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Bioresorbable Implants Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Bioresorbable Implants Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Bioresorbable Implants Market Value, By Material Type, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Bioresorbable Implants Market Value, By Material Type, 2022-2033 (US$ Billion)
Table 7 Global Bioresorbable Implants Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Bioresorbable Implants Market Value, By Application, 2022-2033 (US$ Billion)
Table 9 Global Bioresorbable Implants Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Bioresorbable Implants Market Value, By End-User, 2022-2033 (US$ Billion)
Table 11 Global Bioresorbable Implants Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Bioresorbable Implants Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America Bioresorbable Implants Market Value, By Material Type, 2022-2033 (US$ Billion)
Table 14 North America Bioresorbable Implants Market Value, By Application, 2022-2033 (US$ Billion)
Table 15 North America Bioresorbable Implants Market Value, By End-User, 2022-2033 (US$ Billion)
Table 16 North America Bioresorbable Implants Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 South America Bioresorbable Implants Market Value, By Material Type, 2022-2033 (US$ Billion)
Table 18 South America Bioresorbable Implants Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 South America Bioresorbable Implants Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 South America Bioresorbable Implants Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Bioresorbable Implants Market Value, By Material Type, 2022-2033 (US$ Billion)
Table 22 Europe Bioresorbable Implants Market Value, By Application, 2022-2033 (US$ Billion)
Table 23 Europe Bioresorbable Implants Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 Europe Bioresorbable Implants Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 Asia-Pacific Bioresorbable Implants Market Value, By Material Type, 2022-2033 (US$ Billion)
Table 26 Asia-Pacific Bioresorbable Implants Market Value, By Application, 2022-2033 (US$ Billion)
Table 27 Asia-Pacific Bioresorbable Implants Market Value, By End-User, 2022-2033 (US$ Billion)
Table 28 Asia-Pacific Bioresorbable Implants Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa Bioresorbable Implants Market Value, By Material Type, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa Bioresorbable Implants Market Value, By Application, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa Bioresorbable Implants Market Value, By End-User, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa Bioresorbable Implants Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 Bioretec Ltd: Overview
Table 34 Bioretec Ltd: Product Portfolio
Table 35 Bioretec Ltd: Key Developments
Table 36 Stryker Corporation: Overview
Table 37 Stryker Corporation: Product Portfolio
Table 38 Stryker Corporation: Key Developments
Table 39 CONMED Corporation: Overview
Table 40 CONMED Corporation: Product Portfolio
Table 41 CONMED Corporation: Key Developments
Table 42 Syntellix AG: Overview
Table 43 Syntellix AG: Product Portfolio
Table 44 Syntellix AG: Key Developments
Table 45 Johnson & Johnson Medical Devices (DePuy Synthes): Overview
Table 46 Johnson & Johnson Medical Devices (DePuy Synthes): Product Portfolio
Table 47 Johnson & Johnson Medical Devices (DePuy Synthes): Key Developments
Table 48 Zimmer Biomet: Overview
Table 49 Zimmer Biomet: Product Portfolio
Table 50 Zimmer Biomet: Key Developments
Table 51 NuVasive Inc.: Overview
Table 52 NuVasive Inc.: Product Portfolio
Table 53 NuVasive Inc.: Key Developments
Table 54 KLS Martin Group: Overview
Table 55 KLS Martin Group: Product Portfolio
Table 56 KLS Martin Group: Key Developments
Table 57 Smith+Nephew: Overview
Table 58 Smith+Nephew: Product Portfolio
Table 59 Smith+Nephew: Key Developments
Table 60 Evonik Industries AG: Overview
Table 61 Evonik Industries AG: Product Portfolio
Table 62 Evonik Industries AG: Key Developments
LIST OF FIGURES
Figure 1 Global Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Bioresorbable Implants Market Share, By Material Type, 2024 & 2033 (%)
Figure 3 Global Bioresorbable Implants Market Share, By Application, 2024 & 2033 (%)
Figure 4 Global Bioresorbable Implants Market Share, By End-User, 2024 & 2033 (%)
Figure 5 Global Bioresorbable Implants Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global Bioresorbable Implants Market Y-o-Y Growth, By Material Type, 2023-2033 (%)
Figure 7 Metallic Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 8 Polymers Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 9 PLGA- Poly lactic-co-glycolic acid Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 10 PLLA- Poly L-lactide Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 11 PGA- Polyglycolic Acid Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 12 PLA- Polylactic Acid Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 13 Others Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 14 Global Bioresorbable Implants Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 15 Cardiovascular Application in Global Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 16 Orthopedics Application in Global Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 17 Others Application in Global Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 18 Global Bioresorbable Implants Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 19 Hospitals End-User in Global Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 20 Ambulatory Surgical Centers End-User in Global Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 21 Others End-User in Global Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 22 Global Bioresorbable Implants Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 23 North America Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 24 North America Bioresorbable Implants Market Share, By Material Type, 2024 & 2033 (%)
Figure 25 North America Bioresorbable Implants Market Share, By Application, 2024 & 2033 (%)
Figure 26 North America Bioresorbable Implants Market Share, By End-User, 2024 & 2033 (%)
Figure 27 North America Bioresorbable Implants Market Share, By Country, 2024 & 2033 (%)
Figure 28 South America Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 29 South America Bioresorbable Implants Market Share, By Material Type, 2024 & 2033 (%)
Figure 30 South America Bioresorbable Implants Market Share, By Application, 2024 & 2033 (%)
Figure 31 South America Bioresorbable Implants Market Share, By End-User, 2024 & 2033 (%)
Figure 32 South America Bioresorbable Implants Market Share, By Country, 2024 & 2033 (%)
Figure 33 Europe Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 34 Europe Bioresorbable Implants Market Share, By Material Type, 2024 & 2033 (%)
Figure 35 Europe Bioresorbable Implants Market Share, By Application, 2024 & 2033 (%)
Figure 36 Europe Bioresorbable Implants Market Share, By End-User, 2024 & 2033 (%)
Figure 37 Europe Bioresorbable Implants Market Share, By Country, 2024 & 2033 (%)
Figure 38 Asia-Pacific Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 39 Asia-Pacific Bioresorbable Implants Market Share, By Material Type, 2024 & 2033 (%)
Figure 40 Asia-Pacific Bioresorbable Implants Market Share, By Application, 2024 & 2033 (%)
Figure 41 Asia-Pacific Bioresorbable Implants Market Share, By End-User, 2024 & 2033 (%)
Figure 42 Asia-Pacific Bioresorbable Implants Market Share, By Country, 2024 & 2033 (%)
Figure 43 Middle East and Africa Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 44 Middle East and Africa Bioresorbable Implants Market Share, By Material Type, 2024 & 2033 (%)
Figure 45 Middle East and Africa Bioresorbable Implants Market Share, By Application, 2024 & 2033 (%)
Figure 46 Middle East and Africa Bioresorbable Implants Market Share, By End-User, 2024 & 2033 (%)
Figure 47 Bioretec Ltd: Financials
Figure 48 Stryker Corporation: Financials
Figure 49 CONMED Corporation: Financials
Figure 50 Syntellix AG: Financials
Figure 51 Johnson & Johnson Medical Devices (DePuy Synthes): Financials
Figure 52 Zimmer Biomet: Financials
Figure 53 NuVasive Inc.: Financials
Figure 54 KLS Martin Group: Financials
Figure 55 Smith+Nephew: Financials
Figure 56 Evonik Industries AG: Financials
Figure 1 Global Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Bioresorbable Implants Market Share, By Material Type, 2024 & 2033 (%)
Figure 3 Global Bioresorbable Implants Market Share, By Application, 2024 & 2033 (%)
Figure 4 Global Bioresorbable Implants Market Share, By End-User, 2024 & 2033 (%)
Figure 5 Global Bioresorbable Implants Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global Bioresorbable Implants Market Y-o-Y Growth, By Material Type, 2023-2033 (%)
Figure 7 Metallic Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 8 Polymers Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 9 PLGA- Poly lactic-co-glycolic acid Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 10 PLLA- Poly L-lactide Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 11 PGA- Polyglycolic Acid Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 12 PLA- Polylactic Acid Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 13 Others Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 14 Global Bioresorbable Implants Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 15 Cardiovascular Application in Global Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 16 Orthopedics Application in Global Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 17 Others Application in Global Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 18 Global Bioresorbable Implants Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 19 Hospitals End-User in Global Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 20 Ambulatory Surgical Centers End-User in Global Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 21 Others End-User in Global Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 22 Global Bioresorbable Implants Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 23 North America Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 24 North America Bioresorbable Implants Market Share, By Material Type, 2024 & 2033 (%)
Figure 25 North America Bioresorbable Implants Market Share, By Application, 2024 & 2033 (%)
Figure 26 North America Bioresorbable Implants Market Share, By End-User, 2024 & 2033 (%)
Figure 27 North America Bioresorbable Implants Market Share, By Country, 2024 & 2033 (%)
Figure 28 South America Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 29 South America Bioresorbable Implants Market Share, By Material Type, 2024 & 2033 (%)
Figure 30 South America Bioresorbable Implants Market Share, By Application, 2024 & 2033 (%)
Figure 31 South America Bioresorbable Implants Market Share, By End-User, 2024 & 2033 (%)
Figure 32 South America Bioresorbable Implants Market Share, By Country, 2024 & 2033 (%)
Figure 33 Europe Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 34 Europe Bioresorbable Implants Market Share, By Material Type, 2024 & 2033 (%)
Figure 35 Europe Bioresorbable Implants Market Share, By Application, 2024 & 2033 (%)
Figure 36 Europe Bioresorbable Implants Market Share, By End-User, 2024 & 2033 (%)
Figure 37 Europe Bioresorbable Implants Market Share, By Country, 2024 & 2033 (%)
Figure 38 Asia-Pacific Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 39 Asia-Pacific Bioresorbable Implants Market Share, By Material Type, 2024 & 2033 (%)
Figure 40 Asia-Pacific Bioresorbable Implants Market Share, By Application, 2024 & 2033 (%)
Figure 41 Asia-Pacific Bioresorbable Implants Market Share, By End-User, 2024 & 2033 (%)
Figure 42 Asia-Pacific Bioresorbable Implants Market Share, By Country, 2024 & 2033 (%)
Figure 43 Middle East and Africa Bioresorbable Implants Market Value, 2022-2033 (US$ Billion)
Figure 44 Middle East and Africa Bioresorbable Implants Market Share, By Material Type, 2024 & 2033 (%)
Figure 45 Middle East and Africa Bioresorbable Implants Market Share, By Application, 2024 & 2033 (%)
Figure 46 Middle East and Africa Bioresorbable Implants Market Share, By End-User, 2024 & 2033 (%)
Figure 47 Bioretec Ltd: Financials
Figure 48 Stryker Corporation: Financials
Figure 49 CONMED Corporation: Financials
Figure 50 Syntellix AG: Financials
Figure 51 Johnson & Johnson Medical Devices (DePuy Synthes): Financials
Figure 52 Zimmer Biomet: Financials
Figure 53 NuVasive Inc.: Financials
Figure 54 KLS Martin Group: Financials
Figure 55 Smith+Nephew: Financials
Figure 56 Evonik Industries AG: Financials
